Skip to Content

MYLAN 2150 (Meclofenamate Sodium 50 mg)

Pill with imprint MYLAN 2150 is Red, Capsule-shape and has been identified as Meclofenamate Sodium 50 mg. It is supplied by Mylan Pharmaceuticals Inc..

Meclofenamate is used in the treatment of osteoarthritis; premenstrual dysphoric disorder; period pain; pain; rheumatoid arthritis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. FDA has not classified the drug for risk during pregnancy. Meclofenamate 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2150

Meclofenamate sodium 50 mg MYLAN 2150
Meclofenamate sodium 50 mg MYLAN 2150 Front
Meclofenamate sodium 50 mg MYLAN 2150 Back
Meclofenamate sodium 50 mg MYLAN 2150

Meclofenamate Sodium

Imprint
MYLAN 2150
Strength
50 mg
Color
Red
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
N - Not classified
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-2150
Inactive Ingredients
silicon dioxide, FD&C Blue No. 1, gelatin, magnesium stearate, microcrystalline cellulose, corn starch, FD&C Red No. 3, sodium lauryl sulfate, titanium dioxide, D&C Yellow No. 10

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.